임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

28건 표시

3상모집 예정· Schizophrenia; Psychosis
조현병 성인 환자에서 24주 및 52주 치료 후 크산올리딘/트로스피움(XT)의 인지장애 개선 효능 평가 연구
A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia
협력: BMS
상세 →NCT07084831
3상모집 예정· Pulmonary Fibrosis
폐섬유증 환자에서 애드밀파란트의 안전성 및 내약성을 평가하는 장기 추적 연구
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
리드: BMS
상세 →NCT07441408
4상모집 예정· Untreated Melanoma
A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India
리드: BMS
상세 →NCT07459543
해당없음모집 예정· Lung Carcinoma
An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial
협력: BMS
상세 →NCT07615764
2상모집 예정· Lymphoma
GLORY: Glofit-GemOx With Liso-Cel For Lymphoma
협력: BMS
상세 →NCT07711483
3상모집 예정· Non-Small Cell Lung Cancer
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
리드: BMS
상세 →NCT07680790
1/2상모집 예정· Arthritis, Rheumatoid
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
리드: BMS
상세 →NCT07412704
3상모집 예정· Irritability Associated With Autism Spectrum Disorder
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder
리드: BMS
상세 →NCT07285798
3상모집 예정· Irritability Associated With Autism Spectrum Disorder
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism
리드: BMS
상세 →NCT07284745
3상모집 예정· Schizophrenia
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
협력: BMS
상세 →NCT07686263
1상모집 예정· AQP4+ NMOSD
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients
협력: BMS
상세 →NCT07573332
2상모집 예정· Chronic Immune Thrombocytopenia
Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)
리드: BMS
상세 →NCT07603557
2상모집 예정· Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
리드: BMS
상세 →NCT07680764
4상모집 예정· Healthy Volunteers
Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers
협력: BMS
상세 →NCT07681076
2상모집 예정· Solid Tumors
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
리드: BMS
상세 →NCT07492680
1상모집 예정· KMT2A-rearranged
Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML
협력: BMS
상세 →NCT07355335
단계 미표기모집 예정· Lung Cancer
AIRCARE (Air Pollution and Cancer Research Ecosystem): Center for Advanced Research on Environmental Health and Lung Cancer Risk
협력: BMS
상세 →NCT07553598
1상모집 예정· Healthy Volunteers
Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants
리드: BMS
상세 →NCT07629999
3상모집 예정· Multiple Myeloma
Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
협력: BMS, 리제네론, 사노피
상세 →NCT07624513
1상모집 예정· Large B-cell Lymphoma
Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas
협력: BMS
상세 →NCT07608731
단계 미표기모집 예정· Non-Small Cell Lung Cancer
Repotrectinib Post-Marketing Surveillance in Korean Patients With ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) or Solid Tumors Harboring a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion
리드: BMS
상세 →NCT07599007
2상모집 예정· Mesothelioma
SELECTmeso A Trial for Patients With Relapsed Malignant Mesothelioma SELECTmeso1 A Trial of BMS-986504 in Patients With MTAP-deficient Relapsed Mesothelioma
협력: BMS
상세 →NCT07602946
단계 미표기모집 예정· Myelodysplastic Syndromes (MDS)
Asia Myelodysplastic Syndrome (MDS) Registry
리드: BMS
상세 →NCT07355478
2상모집 예정· Relapsed or Refractory Multiple Myeloma (RRMM)
A Phase 2, Single Arm Multicenter, Study Testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
협력: BMS
상세 →NCT07348393
2상모집 예정· Alzheimers Disease
The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheimer's Disease Who Are Currently Treated With Lecanemab.
협력: BMS
상세 →NCT07212062
4상모집 예정· Schizophrenia
An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients
협력: BMS
상세 →NCT06923891
4상모집 예정· Schizophrenia Disorders
An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia
협력: BMS
상세 →NCT06924255
단계 미표기모집 예정· Lung Cancer Non Small Cell
Comprehensive Demographics and Clinical Profile of NSCLC Patients
협력: BMS
상세 →NCT06725537

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.